Comparative effects of rapid bolus administration of aqueous amiodarone versus 10-minute Cordarone I.V. Infusion on mean arterial blood pressure in conscious dogs

Cardiovascular Drugs and Therapy

Volumn 18, Issue 5, 2004, Pages 345-351

  Somberg, John Charin ^a,c   Cvetanovic, Ivana ^a   Ranade, Vasant ^b   Molnar, Janos ^b  

^a RUSH UNIVERSITY   (United States)

^b Academic Pharmaceutical Inc   (United States)

^c NONE   (United States)

Author keywords

Antiarrhythmic agents; Aqueous amiodarone; Blood pressure; Cordarone IV; Hypotension; Intravenous amiodarone

Indexed keywords

AMIO AQUEOUS; AMIODARONE; BENZYL ALCOHOL; EXCIPIENT; PLACEBO; POLYSORBATE;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; BLOOD PRESSURE MONITORING; BOLUS INJECTION; CONSCIOUSNESS; CONTROLLED STUDY; DEVICE; DOG; DRUG EFFECT; DRUG FORMULATION; DRUG LABELING; DRUG SAFETY; FEMALE; HYPOTENSION; HYPOTHESIS; INFUSION; INSTRUMENTATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; STANDARD; TELEMETRY;

AMIODARONE; ANIMALS; BLOOD PRESSURE; CHEMISTRY, PHARMACEUTICAL; DOGS; FEMALE; HYPOTENSION; INFUSIONS, INTRAVENOUS; MALE; TIME FACTORS; VASODILATOR AGENTS;

EID: 17644398233     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-005-5058-8     Document Type: Article

References (33)

1. Schutzenberger W, Leisch F, Kerschner K, Harringer W, Herbinger W. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation. Br Heart J 1989;62:367-371.
2. Mooss AN, Mohiuddin SM, Hee TT, et al. Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia. Am J Cardiol 1990;65:609-614.
3. Nalos PC, Ismail Y, Pappas JM, Nyitray W, DonMichael TA. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation. Am Heart J 1991;122:1629-1632.
4. Ochi RP, Goldenberg IF, Almquist A, et al. Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease. Am J Cardiol 1989;64:599-603.
5. Figa FH, Gow RM, Hamilton RM, Freedom RM. Clinical efficacy and safety of intravenous Amiodarone in infants and children. Am J Cardiol 1994;74:573-577.
6. Helmy I, Herre JM, Gee G, et al. Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias. J Am Coll Cardiol 1988;12:1015-1022.
7. Klein RC, Machell C, Rushforth N, Standefur J. Efficacy of intravenous amiodarone as short-term treatment for refractory ventricular tachycardia. Am Heart J 1988;115:96-101.
8. Leak D. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient. Am. Heart J 1986;111:456-462.
9. Somberg JC, Tepper D, Keefe DL. Incessant VT treated with IV amiodarone: Rapid onset of action with a long half-life agent. (Abstract) J Clin Pharmacol 1986;26:543.
10. Morady F, Scheinman MM, Shen E, Shapiro W, Sung RJ, DiCarlo L. Intravenous amiodarone in the acute treatment of recurrent symptomatic ventricular tachycardia. Am J Cardiol 1983;51:156-159.
11. Horowitz LN, Mattleman SJ, Spielman SR, et al. Intravenous amiodarone loading for ventricular tachycardia. (Abstract) Circulation 1982;66(Suppl II):II-222.
12. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871-878.
13. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002;346:884-890.
14. Somberg JC, Bailin SJ, Haffajee CI, et al. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. Am J Cardiol 2002;90:853-859.
15. Installe E, Schoevaerdts JC, Gadisseux P, Charles S, Tremouroux J. Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations. J Thorac Cardiovasc Surg 1981;81:302-308.
16. Kosinski EJ, Albin JB, Young E, Lewis SM, LeLand OS Jr. Hemodynamic effects of intravenous amiodarone. J Am Coll Cardiol 1984;4:565-570.
17. Levine JH, Massumi A, Scheinman MM, et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. J Am Coll Cardiol 1996;27:67-75.
18. Scheinman MM, Levine JH, Cannom DS, et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 1995;92:3264-3272.
19. Kowey PR, Levine JH, Herre JM, et al. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 1995;92:3255-3263.
20. Thomson PDR, Montvale NJ, ed. Cordarone Intravenous drug specific package insert. In: Physicians' Desk Reference. 57th edition, 2003;3387-3390
21. Gough WB, Zeiler RH, Barreca P, El-Sherif N. Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs. J Cardiovasc Pharmacol 1982;4:375-380.
22. Platou ES, Refsum H. Acute electrophysiologic and blood pressure effects of amiodarone and its solvent in the dog. Acta Pharmacol Toxicol (Copenh) 1986;58:163-168.
23. Munoz A, Karila P, Gallay P, et al. A randomized hemodynamic comparison of intravenous amiodarone with and without Tween 80. Eur Heart J 1988;9:142-148.
24. Sicart M, Besse P, Choussat A, Bricaud H. Hemodynamic effects of intravenous amiodarone in humans. (French) Arch Mal Coeur Vaiss 1977;70:219-227.
25. Yasaka WJ, Eichbaum FW, Oga S. Antiarrhythmic effects of solvents: III. Effects of propylene glycol and benzyl alcohol on contractile force of isolated rabbit heart. Cardiovasc Res 1979;13:717-722.
26. Gruber CM. The pharmacology of benzyl alcohol and its esters. II. Some of the effects of benzyl alcohol, benzyl benzoate and benzyl acetate when injected intravenously upon the respiratory and circulatory systems. J Lab Clin Med 1923;9:92-112.
27. Somberg JC, Cao W, Ranade V, Cvetanovic I, Molnar J. Pharmacology and toxicology of a new aqueous formulation of intravenous amiodarone (Amio-Aqueous) in comparison to Cordarone® IV. In press. Am J Ther 2005;Jan-Feb.
28. Torres-Arraut E, Singh S, Pickoff AS. Electrophysiologic effects of Tween 80 in the myocardium and specialized conduction system of the canine heart. J Electrocardiol 1984;17:145-151.
29. Path GJ, Dai XZ, Schwartz JS, Benditt DG, Bache EJ. Effects of amiodarone with and without polysorbate 80 on myocardial oxygen consumption and coronary blood flow during treadmill exercise in the dog. J Cardiovasc Pharmacol 1991;18:11-16.
30. Bellotti G, Silva LA, Esteves Filho A, et al. Hemodynamic effects of intravenous administration of amiodarone in congestive heart failure from chronic Chagas' disease. Am J Cardiol 1983;52:1046-1049.
31. Remme WJ, van Hoogenhuyze DC, Kruyssen DA, Krauss XH, Storm CJ. Amiodarone. Haemodynamic profile during intravenous administration and effect on pacing-induced ischaemia in man. Drugs 1985;29(Suppl 3):11-22.
32. Remme WJ, Kruyssen HA, Look MP, van Hoogenhuyze DC, Krauss XH. Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function. Am Heart J 1991;122(1pt1):96-103.
33. Gallik DM, Singer I, Meissner MD, Molnar J, Somberg JC. Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone. Am J Cardiol 2002;90(9):964-968.